In Setback For Glaxo, European Court Clears Paxil Generics

Law360, New York (January 20, 2005, 12:00 AM EST) -- In a blow to U.K. drug maker GlaxoSmithKline PLC, the European Court of Justice has ruled that generic drug makers should be allowed to market versions of its top-selling anti-depressant Seroxat, marketed in the U.S. as Paxil.

The appeals court upheld a ruling by Danish authorities to approve generic drugs based on the active ingredients in Paxil, known in Europe as Seroxat.

Glaxo had appealed the Danish ruling, arguing that the generic drug makers were using "a different salt form" of Paxil's active ingredient and should...
To view the full article, register now.